Dr. Duke is Interim CEO at Xilis. He has extensive experience as an executive leader, attorney, and board member, guiding strategy for life sciences companies ranging from startups to multi-billion-dollar pharma companies. Dr. Duke received his B.S. in Microbiology from the University of California, Santa Barbara, his Ph.D. in Molecular Biochemistry and Biophysics from Illinois Institute of Technology, and his J.D. from Loyola University Chicago School of Law.
Thomas Duke, PhD, JD
Interim Chief Executive Officer
Dr. Duke is Interim CEO at Xilis. He has extensive experience as an executive leader, attorney, and board member, guiding strategy for life sciences companies ranging from startups to multi-billion-dollar pharma companies. Dr. Duke received his B.S. in Microbiology from the University of California, Santa Barbara, his Ph.D. in Molecular Biochemistry and Biophysics from Illinois Institute of Technology, and his J.D. from Loyola University Chicago School of Law.
Elena Helman, PhD
VP, Data Science and Bioinformatics
Dr. Helman is Vice President of Data Science and Bioinformatics at Xilis. She has over 10 years experience in the cancer genomics and diagnostic space, bringing together data analytics and computational tools with a deep knowledge of cancer biology. She has developed diagnostic products across the regulatory landscape, led algorithm design, and biopharma partnerships. Dr Helman was previously Director of Bioinformatics at Guardant Health. She received her PhD in Bioinformatics and Integrative Genomics from the Harvard-MIT Division of Health Sciences and Technology.
Elena Helman, PhD
VP, Data Science and Bioinformatics
Dr. Helman is Vice President of Data Science and Bioinformatics at Xilis. She has over 10 years experience in the cancer genomics and diagnostic space, bringing together data analytics and computational tools with a deep knowledge of cancer biology. She has developed diagnostic products across the regulatory landscape, led algorithm design, and biopharma partnerships. Dr Helman was previously Director of Bioinformatics at Guardant Health. She received her PhD in Bioinformatics and Integrative Genomics from the Harvard-MIT Division of Health Sciences and Technology.
